Xtant Medical Holdings, Inc.

XTNT · AMEX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$16,449$660-$8,485-$4,849
Dep. & Amort.$4,224$3,174$1,292$1,332
Deferred Tax$21-$1,901$0$0
Stock-Based Comp.$4,117$2,739$2,464$2,209
Change in WC-$5,349-$3,634-$2,811$793
Other Non-Cash$1,540-$10,553$2,199$954
Operating Cash Flow-$11,896-$9,515-$5,341$439
Investing Activities
PP&E Inv.-$4,113-$1,456-$1,764-$2,115
Net Acquisitions$0-$23,503$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$383$175$205$225
Investing Cash Flow-$3,730-$24,784-$1,559-$1,890
Financing Activities
Debt Repay.$12,433$6,180-$291-$592
Stock Issued$4,456$14,011$9,311$18,426
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$816-$500$0-$337
Financing Cash Flow$16,073$19,691$9,020$17,497
Forex Effect-$149$24$0$0
Net Chg. in Cash$298-$14,584$2,120$16,046
Supplemental Information
Beg. Cash$5,923$20,507$18,387$2,341
End Cash$6,221$5,923$20,507$18,387
Free Cash Flow-$16,009-$10,971-$7,105-$1,676
Xtant Medical Holdings, Inc. (XTNT) Financial Statements & Key Stats | AlphaPilot